Choroidal disease
Showing 9976 - 10000 of >10,000
Chronic Kidney Disease Trial in Dalian (optimal start time, late start time)
Active, not recruiting
- Chronic Kidney Disease
- optimal start time
- late start time
-
Dalian, Liaoning, Chinathe First Affiliated Hospital of Dalian Medical University
Apr 15, 2022
REM Sleep Behavior Disorder, Parkinson Disease Trial in Hangzhou (Idebenone, Placebo oral tablet)
Recruiting
- REM Sleep Behavior Disorder
- Parkinson Disease
- Idebenone
- Placebo oral tablet
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
Jul 14, 2021
Longitudinal Observational Study of Severe Asthma
Recruiting
- Asthma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
HAM/TSP Trial run by the NINDS (Teriflunomide)
Recruiting
- HAM/TSP
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting
- Takayasu's Arteritis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Data Collected From Individuals Administered Neurobehavioral
Enrolling by invitation
- HIV
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Vascular Diseases, Peripheral Artery Disease, Peripheral Vascular Diseases Trial in Plano (Vascular Rehabilitation)
Terminated
- Vascular Diseases
- +2 more
- Vascular Rehabilitation
-
Plano, TexasBaylor Scott & White Heart Hospital- Plano
Oct 12, 2022
Socio-economic Multifacet Burden of Alopecia Areata and
Not yet recruiting
- Alopecia Areata
-
Toulouse, FranceToulouse University hospital
Oct 17, 2022
HF - Heart Failure Trial in Italy (CPET and related variables evaluation)
Recruiting
- HF - Heart Failure
- CPET and related variables evaluation
-
Milano, Milan, Italy
- +3 more
Oct 2, 2023
Heart Failure Trial (PAC provision at hospital discharge, Control non-intervention; PAC without filter)
Not yet recruiting
- Heart Failure
- PAC provision at hospital discharge
- Control non-intervention; PAC without filter
- (no location specified)
Oct 4, 2023
Acute Ischemic Stroke Trial in France (Intracranial stenting, Optimal medical care, without additional endovascular procedures)
Not yet recruiting
- Acute Ischemic Stroke
- Intracranial stenting
- Optimal medical care, without additional endovascular procedures
-
Amiens, France
- +21 more
Oct 2, 2023
Normative QEEG/ERP Data for Healthy Volunteers
Not yet recruiting
- Healthy
-
Louisville, KentuckyCognision
May 11, 2023
Atherosclerosis Trial in Portland (R-alpha lipoic acid, Placebo)
Active, not recruiting
- Atherosclerosis
- R-alpha lipoic acid
- Placebo
-
Portland, OregonOregon Health & Science University
Apr 19, 2022
Diabetic Kidney Disease Trial in Worldwide (Fulacimstat (BAY1142524), Placebo)
Completed
- Diabetic Kidney Disease
- Fulacimstat (BAY1142524)
- Placebo
-
Dimitrovgrad, Bulgaria
- +26 more
Feb 16, 2022
Primary Progressive Nonfluent Aphasia Trial in Vancouver (Active iTBS, Sham iTBS)
Terminated
- Primary Progressive Nonfluent Aphasia
- Active iTBS
- Sham iTBS
-
Vancouver, British Columbia, CanadaNon-Invasive Neurostimulation Therapies lab, University of Briti
Feb 14, 2022
Endometriosis (Diagnosis), Blood Biomarkers, Endometrium Biomarkers Trial in Paris (Assessment of endometrium and blood
Recruiting
- Endometriosis (Diagnosis)
- +2 more
- Assessment of endometrium and blood biomarkers for endometriosis diagnosis
-
Paris, FranceEndodiag
May 11, 2022
Alzheimer Trial in Alcantarilla, Murcia (device, procedure, behavioral)
Completed
- Alzheimer Disease
- non-invasive neuromodulation through the Nesa device
- +2 more
-
Alcantarilla, Murcia, Spain
- +1 more
Jan 27, 2023
Gastroenteropancreatic Neuroendocrine Tumours
Recruiting
- Gastroenteropancreatic Neuroendocrine Tumor
- 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
-
Milano, ItalyIrccs San Raffaele
Nov 24, 2023
Patient Engagement Trial in New Delhi (Teach back, Standard of care)
Completed
- Patient Engagement
- Teach back
- Standard of care
-
New Delhi, Delhi, IndiaSheetal Chhikara
Mar 21, 2022
Cardiovascular Disease Trial in Ottawa (PiezoRx medical grade pedometer)
Completed
- Cardiovascular Disease
- PiezoRx medical grade pedometer
-
Ottawa, Ontario, Canada
- +1 more
Feb 8, 2022
Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That
Not yet recruiting
- Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
- Inotuzumab Ozogamicin
- (no location specified)
Nov 3, 2022
Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Not yet recruiting
- Breast Cancer
- (no location specified)
Jul 18, 2022
Intestinal Inflammation in People With Primary Immune
Recruiting
- Chronic Granulomatous Disease
- Inflammatory Bowel Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023